SEOM clinical guidelines for the treatment of non-small cell lung cancer (2018)

Non-small cell lung cancer (NSCLC) accounts for up to 85% of all lung cancers. The last few years have seen the development of a new staging system, diagnostic procedures such as liquid biopsy, treatments like immunotherapy, as well as deeper molecular knowledge; so, more options can be offered to p...

Descripción completa

Detalles Bibliográficos
Autores principales: Majem, M., Juan, O., Insa, A., Reguart, N., Trigo, J. M., Carcereny, E., García-Campelo, R., García, Y., Guirado, M., Provencio, M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2018
Materias:
Clinical Guides in Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339680/
https://www.ncbi.nlm.nih.gov/pubmed/30446985
http://dx.doi.org/10.1007/s12094-018-1978-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6339680/
https://www.ncbi.nlm.nih.gov/pubmed/30446985
http://dx.doi.org/10.1007/s12094-018-1978-1

Ejemplares similares